These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1257 related items for PubMed ID: 11146169

  • 1. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L, Pflumio F, Giarratana M, Li X, Titeux M, Izac B, Leteurtre F, Coulombel L, Douay L.
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [Abstract] [Full Text] [Related]

  • 2. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L.
    J Hematother Stem Cell Res; 2001 Apr; 10(2):273-81. PubMed ID: 11359674
    [Abstract] [Full Text] [Related]

  • 3. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D, Goan SR, Junghahn I, Winkler J, Fichtner I, Hermann M, Becker M, de Lima-Hahn E, Henschler R.
    Stem Cells; 1999 Apr; 17(3):152-61. PubMed ID: 10342558
    [Abstract] [Full Text] [Related]

  • 4. Successful short-term ex vivo expansion of NOD/SCID repopulating ability and CAFC week 6 from umbilical cord blood.
    Kusadasi N, van Soest PL, Mayen AE, Koevoet JL, Ploemacher RE.
    Leukemia; 2000 Nov; 14(11):1944-53. PubMed ID: 11069030
    [Abstract] [Full Text] [Related]

  • 5. Preclinical ex vivo expansion of cord blood hematopoietic stem and progenitor cells: duration of culture; the media, serum supplements, and growth factors used; and engraftment in NOD/SCID mice.
    Lam AC, Li K, Zhang XB, Li CK, Fok TF, Chang AM, James AE, Tsang KS, Yuen PM.
    Transfusion; 2001 Dec; 41(12):1567-76. PubMed ID: 11778074
    [Abstract] [Full Text] [Related]

  • 6. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L.
    Blood; 1996 Nov 15; 88(10):3731-40. PubMed ID: 8916937
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J, Mueller G, Zaiss M, Kunz-Schughart LA, Andreesen R, Hennemann B.
    Eur J Haematol; 2006 Aug 15; 77(2):134-44. PubMed ID: 16856909
    [Abstract] [Full Text] [Related]

  • 8. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH, Lee HW, Luongo JL, Simon MC, Bonnet DA.
    Exp Hematol; 2001 Dec 15; 29(12):1465-73. PubMed ID: 11750106
    [Abstract] [Full Text] [Related]

  • 9. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells.
    Piacibello W, Sanavio F, Severino A, Danè A, Gammaitoni L, Fagioli F, Perissinotto E, Cavalloni G, Kollet O, Lapidot T, Aglietta M.
    Blood; 1999 Jun 01; 93(11):3736-49. PubMed ID: 10339480
    [Abstract] [Full Text] [Related]

  • 10. Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells.
    Guenechea G, Segovia JC, Albella B, Lamana M, Ramírez M, Regidor C, Fernández MN, Bueren JA.
    Blood; 1999 Feb 01; 93(3):1097-105. PubMed ID: 9920860
    [Abstract] [Full Text] [Related]

  • 11. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice.
    Conneally E, Cashman J, Petzer A, Eaves C.
    Proc Natl Acad Sci U S A; 1997 Sep 02; 94(18):9836-41. PubMed ID: 9275212
    [Abstract] [Full Text] [Related]

  • 12. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential.
    Conneally E, Eaves CJ, Humphries RK.
    Blood; 1998 May 01; 91(9):3487-93. PubMed ID: 9558409
    [Abstract] [Full Text] [Related]

  • 13. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells.
    Yamaguchi M, Hirayama F, Kanai M, Sato N, Fukazawa K, Yamashita K, Sawada K, Koike T, Kuwabara M, Ikeda H, Ikebuchi K.
    Exp Hematol; 2001 Feb 01; 29(2):174-82. PubMed ID: 11166456
    [Abstract] [Full Text] [Related]

  • 14. Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood.
    Tanavde VM, Malehorn MT, Lumkul R, Gao Z, Wingard J, Garrett ES, Civin CI.
    Exp Hematol; 2002 Jul 01; 30(7):816-23. PubMed ID: 12135681
    [Abstract] [Full Text] [Related]

  • 15. Differential maintenance of primitive human SCID-repopulating cells, clonogenic progenitors, and long-term culture-initiating cells after incubation on human bone marrow stromal cells.
    Gan OI, Murdoch B, Larochelle A, Dick JE.
    Blood; 1997 Jul 15; 90(2):641-50. PubMed ID: 9226164
    [Abstract] [Full Text] [Related]

  • 16. Efficient ex vivo expansion of NOD/SCID-repopulating cells with lympho-myeloid potential in hematopoietic grafts of children with solid tumors.
    Tourino C, Pflumio F, Novault S, Massé A, Guiller M, Bonnet ML, Valteau-Couanet D, Hartmann O, Vainchenker W, Beaujean F, Coulombel L, Turhan AG.
    Hematol J; 2001 Jul 15; 2(2):108-16. PubMed ID: 11424003
    [Abstract] [Full Text] [Related]

  • 17. Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures.
    Giarratana MC, Vergé V, Schmitt C, Bertho JM, Kobari L, Barret C, Douay L.
    Exp Hematol; 2000 Jan 15; 28(1):46-54. PubMed ID: 10658676
    [Abstract] [Full Text] [Related]

  • 18. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
    Miller JS, McCullar V, Verfaillie CM.
    Blood; 1998 Jun 15; 91(12):4516-22. PubMed ID: 9616147
    [Abstract] [Full Text] [Related]

  • 19. Increased expansion and differentiation of cord blood products using a two-step expansion culture.
    McNiece I, Kubegov D, Kerzic P, Shpall EJ, Gross S.
    Exp Hematol; 2000 Oct 15; 28(10):1181-6. PubMed ID: 11027837
    [Abstract] [Full Text] [Related]

  • 20. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L, Meagher R, Welhausen S, Heye M, Brown R, Herzig RH.
    J Hematother Stem Cell Res; 1999 Dec 15; 8(6):609-18. PubMed ID: 10645768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.